Lepu Medical Technology from China has listed its global depository receipts (GDRs) on the SIX Swiss Exchange. According to a press release from SIX, the medtech company has raised proceeds of around 224 million US dollars from the offering. Lepu is the fifth company to list GDRs on the Zurich-based stock exchange since the launch of the China-Switzerland Stock Connect in July 2022.
GDRs are global depository receipts, representing ownership of shares in a foreign company. One GDR corresponds to interest in five A shares of Lepu.
Lepu Medical Technology was founded in Beijing in 1999 and entered the Shenzhen Stock Exchange in 2009. The company specializes in the development, manufacture, and marketing of high-tech medical devices and equipment. According to the information provided, its products are used for cardiovascular procedures, structural heart disease, arrhythmia management, anesthesia, intensive care, in-vitro diagnostics, and general surgery. They are sold in more than 80 countries worldwide.
CEO of SIX Jos Dijsselhof commented: “We see high interest in GDR listings from Chinese companies.” He added: “This is great proof of the attractiveness of the SIX Swiss Exchange for internationally active, growth-seeking companies.”